Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data

Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer

(2010) C D Salcido et al.   BRITISH JOURNAL OF CANCER

Prognostic Significance of OCT4 Expression in Adenocarcinoma of the Lung

(2010) X. Zhang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational simulation study

(2010) Xiuwei Zhu et al.   JOURNAL OF THEORETICAL BIOLOGY

ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy

(2010) Xi-wei Ding et al.   LIFE SCIENCES

The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas

(2010) Feng Li et al.   MEDICAL ONCOLOGY

Metabolic flexibility and cell hierarchy in metastatic cancer

(2010) Michael V. Berridge et al.   MITOCHONDRION

Multiple Drug Resistance Mechanisms in Cancer

(2010) Bruce C. Baguley   MOLECULAR BIOTECHNOLOGY

O2 regulates stem cells through Wnt/β-catenin signalling

(2010) Jolly Mazumdar et al.   NATURE CELL BIOLOGY

Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer

(2010) K-S Lee et al.   ONCOGENE

Lung cancer stem cells: tools and targets to fight lung cancer

(2010) A Eramo et al.   ONCOGENE

SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas

(2010) Thomas Hussenet et al.   PLoS One

Evidence That SOX2 Overexpression Is Oncogenic in the Lung

(2010) Yun Lu et al.   PLoS One

Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

(2010) Shan Deng et al.   PLoS One

Selective targeting of radiation-resistant tumor-initiating cells

(2010) Mei Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma

(2010) William W. Lockwood et al.   PLOS MEDICINE

The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif

(2009) Nadira Taïeb et al.   CANCER LETTERS

Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop

(2009) V. Levina et al.   CANCER RESEARCH

Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis

(2009) E. H. Huang et al.   CANCER RESEARCH

The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆

(2009) Virginia Tirino et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

(2009) Alexei V. Salnikov et al.   INTERNATIONAL JOURNAL OF CANCER

Radiation Response of Cancer Stem-Like Cells From Established Human Cell Lines After Sorting for Surface Markers

(2009) Osama Al-Assar et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework

(2009) Bisrat G. Debeb et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Are Cancer Stem Cells Real? After Four Decades, Debate Still Simmers

(2009) K. Rowan   JNCI-Journal of the National Cancer Institute

Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

(2009) F. Jiang et al.   MOLECULAR CANCER RESEARCH

Stem cells are dispensable for lung homeostasis but restore airways after injury

(2009) A. Giangreco et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

(2009) G. Bertolini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention,,

(2009) G. Karoubi et al.   Interactive Cardiovascular and Thoracic Surgery

Characterization of a stem cell population in lung cancer A549 cells

(2008) Ji-Min Sung et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Octamer 4 Small Interfering RNA Results in Cancer Stem Cell-Like Cell Apoptosis

(2008) T. Hu et al.   CANCER RESEARCH

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung

(2008) Julien D.F. Licchesi et al.   CARCINOGENESIS

Platinum Resistance: The Role of DNA Repair Pathways

(2008) L. P. Martin et al.   CLINICAL CANCER RESEARCH

Sox2 is important for two crucial processes in lung development: Branching morphogenesis and epithelial cell differentiation

(2008) Cristina Gontan et al.   DEVELOPMENTAL BIOLOGY

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute

c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications

(2008) H.T. Hassan   LEUKEMIA RESEARCH

The branching programme of mouse lung development

(2008) Ross J. Metzger et al.   NATURE

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

(2008) K A Kwei et al.   ONCOGENE

Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties

(2008) Vera Levina et al.   PLoS One

Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells

(2008) Yu-Chih Chen et al.   PLoS One

Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours

(2008) Virginia Tirino et al.   PLoS One

Cancer stem cell markers in common cancers – therapeutic implications

(2008) Thomas Klonisch et al.   TRENDS IN MOLECULAR MEDICINE